Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Bayer (FSE:BAY; BAY) will temporarily suspend worldwide marketing of Trasylol aprotinin following requests from regulatory agencies in Germany, Canada and
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury